Business Context and Reporting Period
Company: Community Health Systems, Inc.
Filing Type: Form 10-Q (Unaudited)
Period Ended: September 30, 2008
Overview: The Company is the largest publicly traded operator of hospitals in the U.S. by facility count and revenue. As of the reporting date, it operated 116 general acute care hospitals in continuing operations. The period reflects the integration of the Triad Hospitals acquisition (completed July 2007) and the sale of several hospitals classified as discontinued operations.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sep 30, 2008 |
Three Months Ended Sep 30, 2007 |
Nine Months Ended Sep 30, 2008 |
Nine Months Ended Sep 30, 2007 |
|---|---|---|---|---|
| Net Operating Revenues | $2,772,860 | $2,247,009 | $8,191,014 | $4,599,152 |
| Income from Operations | $253,067 | $184,909 | $733,697 | $423,579 |
| Net Income | $50,384 | $10,460 | $158,404 | $118,547 |
| Diluted EPS (Net Income) | $0.53 | $0.11 | $1.67 | $1.25 |
| Cash from Operating Activities | N/A | N/A | $685,056 | $404,650 |
| Cash and Equivalents (Balance Sheet) | $341,884 | N/A | N/A | N/A |
| Total Debt (Current + Long-term) | $8,908,429 | N/A | N/A | N/A |
Note: Total Debt calculated as Current maturities of long-term debt ($19,647) plus Long-term debt ($8,888,782) as of September 30, 2008.
Material Changes vs. Prior Period
- Revenue Growth: Net operating revenues increased 23.4% for the quarter and 78.1% for the nine-month period compared to the prior year. This growth is primarily driven by the inclusion of Triad hospitals and a 21.9% increase in adjusted admissions for the quarter.
- Profitability: Net income surged 381.7% for the quarter and 33.6% for the nine-month period. Income from continuing operations before taxes increased from $31.4 million to $83.6 million (quarter) and $211.6 million to $248.2 million (nine months).
- Expense Ratios: Operating expenses (excluding depreciation) decreased as a percentage of revenue to 86.2% for the quarter from 87.3% in the prior year, driven by efficiency improvements. However, interest expense increased significantly ($32.6 million for the quarter) due to higher debt levels and interest rates associated with the Triad acquisition financing.
- Discontinued Operations: The Company sold 11 hospitals during the nine months ended September 30, 2008, resulting in a net gain of $5.7 million on discontinued operations for the period, compared to a loss of $12.0 million in the prior year.
Guidance, Outlook, and Risks
- Outlook: Management expects to continue realizing synergies from the Triad acquisition, estimating $38 million realized in the quarter and $115 million for the nine months. The Company plans to selectively pursue additional acquisitions and complete replacement hospital construction projects.
- Liquidity: The Company maintains $1.05 billion in available borrowing capacity under its New Credit Facility (including a $750 million revolver and $300 million delayed draw term loan). Management believes internal cash flows and available credit are sufficient for the next 12 months.
- Regulatory Risks:
- False Claims Act Investigation: The DOJ is investigating potential violations regarding federal matching funds for Medicaid in New Mexico, estimating ineligible payments of approximately $27.5 million. The Company is negotiating a resolution.
- Medicaid Reimbursement: The Company faced an $8.0 million annual reduction in expected Indiana Medicaid payments due to state program changes.
- Legal Proceedings: Several qui tam (whistleblower) cases and class actions regarding billing practices and uninsured patient rates are pending. Management believes these will not have a material adverse effect, though outcomes are uncertain.
- Debt Covenants: The New Credit Facility and Senior Notes contain restrictive covenants regarding leverage ratios, interest coverage, and restrictions on dividends and stock repurchases.
Investor Verification Checklist
- Debt Service Capacity: Verify the Company's ability to service approximately $8.9 billion in debt, particularly given the high interest expense ($487.8 million for nine months) and restrictive covenants.
- Reimbursement Trends: Monitor the resolution of the New Mexico DOJ investigation and the impact of Medicaid payment reductions in Indiana on future margins.
- Acquisition Integration: Assess the realization of projected synergies from the Triad acquisition and the performance of same-store hospitals (which grew 8.2% in revenue for the quarter).
- Capital Expenditures: Review the $295 million estimated cost for required replacement hospital construction and the impact on future cash flows.
- Allowance for Doubtful Accounts: Scrutinize the $1.1 billion allowance for doubtful accounts and the Company's assumptions regarding self-pay collections, which are sensitive to economic conditions and Medicaid enrollment changes.